SUSRF(SUSRF)
SUSRF
No analyst ratings available
No analyst price targets available for SUSRF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $1.01B | $1.13B | $1.26B | $1.46B | $1.64B |
| Low | $993M | $1.07B | $1.22B | $1.41B | $1.58B |
| High | $1.04B | $1.17B | $1.30B | $1.51B | $1.69B |
| EBITDA Avg | $206M | $250M | $285M | $387M | $445M |
| Low | $201M | $242M | $275M | $372M | $428M |
| High | $212M | $258M | $294M | $401M | $461M |
| EBIT Avg | $132M | $182M | $220M | $323M | $381M |
| Low | $126M | $174M | $210M | $309M | $364M |
| High | $137M | $190M | $229M | $337M | $398M |
| Net Income Avg | $109M | $151M | $184M | $272M | $322M |
| Low | $104M | $144M | $175M | $260M | $307M |
| High | $113M | $158M | $192M | $284M | $336M |
| EPS Avg | $2.13 | $2.96 | $3.60 | $5.33 | $6.31 |
| Low | $2.03 | $2.83 | $3.44 | $5.09 | $6.02 |
| High | $2.22 | $3.09 | $3.76 | $5.56 | $6.58 |
| Analysts (Rev / EPS) | 5 / 1 | 5 / 1 | 1 / 1 | 2 / 1 | 2 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 |
|---|---|---|---|---|
| Revenue Avg | $258M | $273M | $261M | $268M |
| Low | $248M | $264M | $251M | $258M |
| High | $278M | $280M | $274M | $281M |
| EBITDA Avg | $63M | $65M | $63M | $68M |
| Low | $61M | $63M | $61M | $66M |
| High | $65M | $68M | $66M | $71M |
| EBIT Avg | $42M | $45M | $43M | $49M |
| Low | $40M | $43M | $41M | $47M |
| High | $44M | $48M | $46M | $52M |
| Net Income Avg | $34M | $37M | $35M | $40M |
| Low | $33M | $35M | $34M | $38M |
| High | $36M | $39M | $38M | $43M |
| EPS Avg | $0.67 | $0.72 | $0.69 | $0.79 |
| Low | $0.64 | $0.69 | $0.66 | $0.75 |
| High | $0.71 | $0.77 | $0.74 | $0.84 |
| Analysts (Rev / EPS) | 4 / 1 | 4 / 1 | 2 / 1 | 2 / 1 |